Results of clinical trials testing potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR Convergence 2020. These studies include phase I trials, which test for side effects and a safe dosage; larger phase II trials, which test for effectiveness and further gauge safety; and large phase III trials, which confirm […] READ MORE
30+ presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways Results from three clinical studies conducted in part by LRA-affiliate Lupus Therapeutics (LT) through its trials network 10 lupus presentations by the Accelerating Medicines Partnership Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) program (AMP RA/SLE) NEW YORK, NY, […] READ MORE
NEW YORK, NY, November 9. The Lupus Research Alliance proudly announced today the 2020 Lupus Innovation Award recipients. These seven projects represent a wide breadth of scientific exploration in lupus, probing the development and progression of lupus while pointing to potential treatment approaches. The Lupus Innovation Award offers up to $150,000/year total costs for up […] READ MORE
There is no doubt about it. The research into the mechanisms of pediatric lupus nephritis conducted by Elena Hsieh, MD, at the University of Colorado Anschutz Medical Campus, is driven by her genuine concern for the wellbeing of children—and a lifelong passion for science. With her new grant from the Lupus Research Alliance, Dr. Hsieh—who […] READ MORE
While children with lupus can experience manifestations similar to adults with the disease, children present with more acute illness, more frequent flares, and increased risk of major organ involvement—including those of the heart. With her LRA grant, Joyce Chang, MD, MSCE from Children’s Hospital of Philadelphia, aims to understand why children with lupus are more […] READ MORE
Aaliya Wears All These Hats … and More Lupus Advocate. Human Rights Defender. Teenager. Aaliya Wears All These Hats … and More It takes a brave, compassionate person to look beyond the personal pain of lupus and look for ways to create greater good. And it is even more remarkable when that person is a […] READ MORE
We can’t imagine November without all of you, so we reimagined our annual gala celebration—online. Using the very latest technology, the Lupus Research Alliance will host an unparalleled virtual event featuring inspirational speakers, star-studded performances, surprise celebrity guests, and recognition of the extraordinary contributions of Jenny and Spencer Zwick of Solamere Capital and the LRA […] READ MORE
Join the Lupus Research Alliance in partnership with Handwritten Wines of Yountville, California for our Virtual Pour for A Cure – Taste Wine and Fight Lupus event, all from the comfort of your home. Since we cannot be together physically, let us get together virtually and enjoy an intimate wine tasting experience you will always […] READ MORE
October 22, 2020 Aurinia Pharmaceuticals announced that data taken from a combined analysis of two trials, AURA-LV and AURORA underscored the potential for voclosporin to offer a tool to treat lupus nephritis. Results from 534 patients from both trials was presented at the American Society of Nephrology Kidney Week 2020 meeting by Dr. Brad Rovin, […] READ MORE
October 22, 2020 Great event; I learned a lot and will have a discussion with my doctor about participating in a trial. It was excellent, and the website is very easy to use. I learned that the medicines you take for lupus are not designed for the disease while the ones you take in a […] READ MORE
October 22, 2020 To take or not to take the COVID-19 vaccine when one is available — that is the question on everyone’s minds, and we need all of your answers to accurately represent people with lupus and their supporters! As coronavirus vaccines are being developed and tested, the Lupus Research Alliance recently convened a […] READ MORE
October 21, 2020 In a recent study published in Nature Immunology, LRA Lupus Insight Prize recipient Dr. Ignacio Sanz and colleagues found that the immune response in patients hospitalized with severe COVID-19 was different from that in patients with mild disease, and that the immune response in severely ill COVID-19 patients was more like a lupus flare. They saw that among severely ill COVID-19 patients, some immune cells called B cells reproduced unchecked, and […] READ MORE
